A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
Clinical trial NCT07140744 · RECRUITING
Trial details
- NCT number
- NCT07140744
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-22
- Primary completion
- 2027-10-01
- Enrollment
- 7000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.